Zobrazeno 1 - 6
of 6
pro vyhledávání: '"David Bernal-Estévez"'
Autor:
Juan Pablo Ortiz-Aguirre, Esteban Alejandro Velandia-Vargas, Oscar Mauricio Rodríguez-Bohorquez, Diego Amaya-Ramírez, David Bernal-Estévez, Carlos Alberto Parra-López
Publikováno v:
Revista de la Facultad de Medicina, Vol 69, Iss 3 (2021)
Introduction: The progress made in cancer immunotherapy and the clinical response of patients who have undergone this type of therapy have made it the fourth pillar of cancer treatment. Objective: To briefly describe the biological rationale of perso
Externí odkaz:
https://doaj.org/article/4fb162dd21c444eea6d0fa4f8a6a0c84
Autor:
Carlos A Parra-López, David Bernal-Estévez, Liusong Yin, Luis Eduardo Vargas, Carolina Pulido-Calixto, Luz Mary Salazar, J Mauricio Calvo-Calle, Lawrence J Stern
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e100639 (2014)
Malaria is transmitted by Plasmodium-infected anopheles mosquitoes. Widespread resistance of mosquitoes to insecticides and resistance of parasites to drugs highlight the urgent need for malaria vaccines. The most advanced malaria vaccines target spo
Externí odkaz:
https://doaj.org/article/e5ed228e943845fa86593a84728aa52e
Publikováno v:
Revista Colombiana de Cancerología. 21:45-46
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::738d2bbf2ac3f3bd5ee0c931f6bfd3ea
https://doi.org/10.1016/j.rccan.2017.02.005
https://doi.org/10.1016/j.rccan.2017.02.005
Publikováno v:
Revista Colombiana de Cancerología. 21:56-57
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6341120eb6e1b1962fc1c3f88aef5d5
https://doi.org/10.1016/j.rccan.2017.02.027
https://doi.org/10.1016/j.rccan.2017.02.027
Publikováno v:
Frontiers in Immunology. 6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::513d7263231623b6b70720ce1264a8ef
https://doi.org/10.3389/conf.fimmu.2015.05.00285
https://doi.org/10.3389/conf.fimmu.2015.05.00285
Autor:
Claudia Urueña, Paola Lasso, David Bernal-Estevez, Diego Rubio, Ana Janeth Salazar, Mercedes Olaya, Alfonso Barreto, Mauricio Tawil, Lilian Torregrosa, Susana Fiorentino
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-13 (2022)
Abstract Neoadjuvant chemotherapy (NAT) in breast cancer (BC) has been used to reduce tumor burden prior to surgery. However, the impact on prognosis depends on the establishment of Pathological Complete Response (pCR), which is influenced by tumor-i
Externí odkaz:
https://doaj.org/article/a8f890c9820e430a9a4b5b080c0fdc29